Cynosure Group’s ResMed RMD Stock Holding History

Cynosure Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,676	Closed	-$404K	–	414
2025 Q4	$404K	Buy	+1,676	New	+$429K	0.04%	360
2024 Q3	–	Sell	-1,797	Closed	-$344K	–	400
2024 Q2	$344K	Buy	1,797 +140	+8%	+$28.4K	0.06%	323
2024 Q1	$328K	Buy	+1,657	New	+$304K	0.06%	209

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cynosure Group's RMD Position: Q1 2026 in Review

Cynosure Group sold out of ResMed (RMD) in Q1 2026, closing a stake of 1,676 shares — an estimated $404K sold.

Cynosure Group first reported a position in RMD in Q1 2024 and held it in 3 quarters. The position peaked at $404K in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Cynosure Group reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Cynosure Group sold 1,676 ResMed shares in Q1 2026, an estimated $404K.
Cynosure Group first reported a position in ResMed in Q1 2024 and held it in 3 quarters.
Cynosure Group's ResMed position peaked at $404K in Q4 2025.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Cynosure Group's 13F filing for Q1 2026, filed 14 May 2026.